Beam Therapeutics: Great Potential, But Patience Is Needed

2026-02-27 09:40:41 ET

Company Background

Beam Therapeutics Inc. ( BEAM ) was founded by David Liu, J. Keith Joung, and Feng Zhang in 2017. Its headquarters and research hub are in Cambridge, MA, while its manufacturing hub is in Durham, NC. It is one of several gene-editing biotech companies developing novel treatments to cure genetic diseases. Its key focus is a form of gene therapy called base editing, which is proprietary for Beam, using an enzyme to convert DNA bases, for example from C to T or A to G. It is said to offer more consistent gene sequencing outcomes and less genotoxicity than the Crispr Cas-9 technology, which has become better known over the last few years. Beam is the undisputed leader in this particular type of gene editing, which holds great potential....

Read the full article on Seeking Alpha

For further details see: